Elixinol Wellness was established in 2014 with a mission to create a healthier everyday life through the power of hemp and plant-based products.
NEWS & PARTNERSHIPS:
2018
The company entered into a 50/50 JV with Kersey Ag Company to cultivate high-CBD, premium, organic hemp in Colorado.
The company increased its ownership in Elixinol Japan to 50.5%.
2019
The company estableshed sales hubs in the Netherlands, Spain and the UK, with product fulfillment supported by local European contract manufacturers.
The company acquired 25% of Pet Releaf.
The company announced a strategic partnership with Infusion Strategies which the company owns 60% of and RFI holds the other 40%. Elixinol will provide hemp expertize, supply chain stability, highest-quality Full-Spectrum and THC-free hemp CBD extracts and RFI will manage the day to day operations and provide e global supply chain management, all non-CBD ingredients and the manufacturing expertize needed to custom blend formulations for tinctures, CBD-infused powders, capsules and other products. Both parties will contribute to the working capital requirements according to its ownership percentage.
The company signed an exclusive distribution agreement with MedVec International for the sales of Elixinol-branded products and white label products via its existing sales network in the pharmacy and para pharmacy sector for an initial graduated period and provides for an extension for a further three years. The exclusivity of the distribution agreement is dependant on achievement of minimum annual sales targets. The distributor will also be appointed co-exclusive for pharmacy and para pharmacy channels in Austria and Switzerland.
The company signed a 5-year exclusive distribution agreement with 25th Group for sales of Elixinol-branded products through retail channels in Belgium and Luxembourg with the exclusivity being based on achievements of minimum annual sales targets and the distributor will also be co-exclusive for retail channels including specialty and national retailers in the Netherlands and Switzerland.
The company signed a 5-year distribution agreement with Harmonia Life Oy for the exclusive distribution of Elixinol-branded products in multiple channels in Finland, based on achievements of minimum annual sales targets.
The company entered into an 18-month exclusive CBD supply agreement with Pet Releaf which can be renewed for multiple ears and has a minimum purchase of 18 million USD worth of products with Pet Releaf paying a deposit of 1,8 million USD through 3 equal payments throughout the agreement.
The company sold its 50,5% interest in Elixinol Japan giving away a non-exclusive licence in Elixinol Global’s trademarks and know-how to allow Elixinol Japan to operate in Japan paying a 3% royalty of its sales.
The company partnered with PharmaCare’s Naturopathica brand for the creation of a co-branded CBD capsule range to be sold via Holland & Barrett.
The company acquired IP rights for microencapsulation technology developed by Bionova internationally and Bionova will be e the exclusive manufacturer and supplier within the European Union of Elixinol products developed using the microencapsulated technology. The company will receive 25,000 USD for each non-European Union country in which Elixinol exploits the microencapsulated technology until patent rights over the microencapsulated technology have been granted in that country and increasing to 50,000 USD annually once the patents rights are granted.
The supply agreement with Pet Releaf was terminated by both companies due to its low-margin.
2020
The company entered into a 2-year exclusive license agreement with Elixinol Japan which automatically renews a further 3 years for the manufacture and sales of Elixinol-branded CBD nutraceuticals in Japan for which the company will receive a 3% royalty in the first year and a 5% royalty afterwards.
The company entered into an exclusive distribution agreement with PharmaCann for the distribution of Elixinol’s CBD products in the Australian market through the therapeutic goods administration’s special access scheme.
2021
The company re-entered the British market through a deal with British Cannabis allowing them to become the sole and exclusive licensee of Elixinol-branded products in the UK for a 3-year term.
The company entered into a 2-year agreement with Health House for the exclusive supply and distribution of Elixnol-branded CBD products under the Therapeutics Goods Administration’s Special Access Scheme.
Distribution agreement with PharmaCann terminated.
2022
The company acquired the Sustainable Nutrition Group.
2024
The company acquired Ananda Food.
The company sold its holdings in Pet Releaf.
The company announced the future availability of 4 of its Mt Elephant products in 800 Coles stores in Australia.
BRANDS:
Ananda Food is a hemp brand offering white-labelling of all of their products in an allergen-free BRCS-accredited facility. The brand sells seed varieties for fibre and grain crop production and processing seed to manufacture hemp food products, bulk hemp and natural feed with low sugar and starch as well as being safe for laminitic-prone, EMS and PPID horses, available domestically and internationally.
Hemp Foods Australia offers functional nutritional products, TGA-approved supplements and functional meal replacements & beverages and is being sold in health, grocery and pharmacies as well as online.
Mt. Elephant offers healthy baking mixes that are sold in grocery stores.
The Australian Super Food Co. is a native ingredient specialist selling native herbs and spices, nutrients boosters, extracts, syrups, paleo granolas, teas and powders as well as some limited editions.
Field Day is a pet brand offering wholefood meal supplements and nutraceuticals products for dogs aiding with digestion, joints, immune system, anxiety, skin and coat and is sold in pet stores as well as online.
Elixinol offers products with CBD and vitamins in product formats such as capsules, sports gels, full-spectrum tinctures and gummies.